TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,911
|
1,982
|
1,935 |
Financial expenses |
1
|
2
|
0 |
Earnings before taxes |
103
|
365
|
540 |
EBITDA |
125
|
367
|
498 |
Total assets |
1,429
|
1,023
|
1,055 |
Current assets |
1,162
|
895
|
224 |
Current liabilities |
502
|
170
|
246 |
Equity capital |
927
|
853
|
809 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
3
![]() |
3
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
64.9%
|
83.4%
|
76.7% |
Turnover per employee |
637
|
661
|
968 |
Profit as a percentage of turnover |
5.4%
|
18.4%
|
27.9% |
Return on assets (ROA) |
7.3%
|
35.9%
|
51.2% |
Current ratio |
231.5%
|
526.5%
|
91.1% |
Return on equity (ROE) |
11.1%
|
42.8%
|
66.7% |
Change turnover |
-81
|
204
|
101 |
Change turnover % |
-4%
|
11%
|
6% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.